IMAX recent weakness a buying opportunity, says JPMorgan JPMorgan views the year-to-date pullback in shares of IMAX as a buying opportunity. The firm believes IMAX is performing well in China while the stock represents the best way to play the "promising" 2015 box office. JPMorgan keeps an Overweight rating on IMAX with a $32 price target.
News For IMAX From The Last 14 Days
Check below for free stories on IMAX the last two weeks.
IMAX adds 19 theaters throughout China with Shanghai Film Corp IMAX announced an agreement with Shanghai Film Corporation and its subsidiaries for 19 IMAX theaters to be located in new construction projects throughout China. Nearly all of the 19 sites, which will be sales agreements, have been identified, with a significant number scheduled for installation before the end of 2015.